This result suggests that TCN1 may affect the activation state of immune cells and the output of inflammation by regulating the vitamin B12-dependent metabolic pathway: its abnormal expression may reshape the methylation metabolic efficiency and antioxidant capacity of immune cells, and ultimately participate in the pathological process of ARDS. Here, TCN1 is linked to acute respiratory distress syndrome.